Primary Biliary Cholangitis clinical trials at UCSF
1 in progress, 1 open to new patients
Safety, Tolerability, and Efficacy of GS 9674 in Adults With Primary Biliary Cholangitis Without Cirrhosis
open to eligible people ages 18–70
The primary objective of this study is to evaluate the safety and tolerability of GS-9674 in adults with primary biliary cholangitis (PBC).
San Francisco, California and other locations